The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer

por Stine, Jessica E., Guo, Hui, Sheng, Xiugui, Han, Xiaoyun, Schointuch, Monica N., Gilliam, Timothy P., Gehrig, Paola A., Zhou, Chunxiao, Bae-Jump, Victoria L.
Publicado 2015

Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer

por Jackson, Amanda L., Sun, Wenchuan, Kilgore, Joshua, Guo, Hui, Fang, Ziwei, Yin, Yajie, Jones, Hannah M., Gilliam, Timothy P., Zhou, Chunxiao, Bae-Jump, Victoria L.
Publicado 2017

Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer

por Guo, Hui, Zhong, Yan, Jackson, Amanda L., Clark, Leslie H., Kilgore, Josh, Zhang, Lu, Han, Jianjun, Sheng, Xiugui, Gilliam, Timothy P., Gehrig, Paola A., Zhou, Chunxiao, Bae, Victoria L.
Publicado 2016

NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo

por Zhang, Lu, Han, Jianjun, Jackson, Amanda L., Clark, Leslie N., Kilgore, Joshua, Guo, Hui, Livingston, Nick, Batchelor, Kenneth, Yin, Yajie, Gilliam, Timothy P., Gehrig, Paola A., Sheng, Xiugui, Zhou, Chunxiao, Bae-Jump, Victoria L.
Publicado 2016

Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer

por Sun, Li, Yin, Yajie, Clark, Leslie H., Sun, Wenchuan, Sullivan, Stephanie A., Tran, Arthur-Quan, Han, Jianjun, Zhang, Lu, Guo, Hui, Madugu, Esther, Pan, Tommy, Jackson, Amanda L., Kilgore, Joshua, Jones, Hannah M., Gilliam, Timothy P., Zhou, Chunxiao, Bae-Jump, Victoria L.
Publicado 2017